Abbott Laboratories, National Retail Properties, UnitedHealth Group And A Big Bank Reporting Upbeat Earnings: CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors named Abbott Laboratories ABT as her final trade.

On Monday, Raymond James maintained Abbott Laboratories with an Outperform and lowered the price target from $123 to $116, while BTIG maintained the stock with a Buy and raised the price target from $125 to $130.

Benzinga's analyst rating data finds a consensus Buy rating on ABT.

Jenny Harrington of Gilman Hill Asset Management said National Retail Properties, Inc. NNN has a 5% dividend yield.

The company’s Board of Directors recently declared a quarterly dividend of 55 cents per share.

Don’t forget to check out our premarket coverage here

Stephen Weiss of Short Hills Capital Partners named UnitedHealth Group Incorporated UNH, which reported better-than-expected Q1 results and increased 2023 guidance.

Joseph Terranova of Virtus Investment Partners picked JPMorgan Chase & Co. JPM, which reported stronger-than-expected results for its first quarter, on Friday.

Price Action: Abbott Laboratories shares rose 0.5% to close at $104.52, while National Retail Properties gained 2% to settle at $43.40 on Monday. UnitedHealth fell 1.3% to $505.35, while JPMorgan rose 0.8% to $139.83 on Monday.

Check This Out: Top 5 Health Care Stocks That May Fall Off A Cliff This Quarter